Abstract
PURPOSE: Portal vein thrombosis is a rare complication of Crohn's disease, and its precise cause and appropriate treatment are not known. We describe a patient with extending portal vein thrombosis in Crohn's disease who was successfully treated with combined anticoagulant therapy. METHOD: Urokinase and tissue plasminogen activator were administered from a catheter inserted into the superior mesenteric artery, and heparin and a serine protease inhibitor also were given intravenously. RESULTS: On admission, thromboembolic occlusion was observed throughout the entire portal venous system in association with massive ascites and remarkable intestinal edema. After administration of combined anticoagulant therapy, thrombus rapidly decreased in size, and color Doppler ultrasonography showed a gradual increase in portal venous flow. The patient had no recurrence of symptoms while receiving warfarin after resolution of thrombus. CONCLUSION: This case report suggests that combined anticoagulant therapy is effective for patients with severe portal vein thrombosis in Crohn's disease and that color Doppler ultrasonography is useful for evaluation of portal venous flow.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Talbot RW, Heppell J, Dozois RR, Beart RW. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140–5.
Brinberg DE, Stefansson TB, Greicius FA, Kahlam SS, Molin C. Portal vein thrombosis in Crohn's disease. Gastrointest Radiol 1991;16:245–7.
Crowe A, Taffinder N, Layer GT, Irvine A, Nicholls RJ. Portal vein thrombosis in a complicated case of Crohn's disease. Postgrad Med J 1992;68:291–3.
Valla D, Denninger MH, Delvigne JM, Rueff B, Benhamou JP. Portal vein thrombosis with ruptured oesophageal varices as presenting manifestation of hereditary protein C deficiency. Gut 1988;29:856–9.
Sas G, Blaski G, Petro I, Griffin JH. A protein S deficient family with portal vein thrombosis. Thromb Haemost 1985;54:724.
Gruenberg SC, Smallridge RC, Rosenberg RD. Inherited antithrombin III deficiency causing mesenteric venous infarction: a new clinical entity. Ann Surg 1975;181:791–4.
Boughton BJ. Hepatic and portal vein thrombosis: closely associated with chronic myeloproliferative disorders. BMJ 1991;302:192–3.
Graef V, Baggenstosis AH, Sauer WG, Spitell JA. Venous thrombosis occurring in nonspecific ulcerative colitis—a necropsy study. Arch Intern Med 1966;117:377–82.
Lake AM, Stauffer JQ, Stuart MJ. Hemostatic alterations in inflammatory bowel disease. Dig Dis 1978;23:897–902.
Lam A, Borda LT, Inwood MJ, Thompson S. Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 1975;68:245–51.
Lee JC, Spittell J, Sauer WG, Owen CA, Thompson JH. Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors. Gastroenterology 1968;54:76–84.
Morowitz DA, Allen LW, Kirsner JB. Thrombocytosis in chronic inflammatory bowel disease. Ann Intern Med 1968;68:1013–21.
Talstad I, Rootwelt K, Gjone E. Thrombocytosis in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1970;8:135–8.
Mori K, Watanabe H, Hiwatashi N, Sugai K, Goto Y. Studies on blood coagulation in ulcerative colitis and Crohn's disease. Tohoku J Exp Med 1980;132:93–101.
Edwards RL, Levine JB, Green R,et al. Activation of blood coagulation in Crohn's disease. Gastroenterology 1987;92:329–37.
Wakefield AJ, Sawyerr AM, Dhillon AP,et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989;2:1057–62.
Author information
Authors and Affiliations
About this article
Cite this article
Tsujikawa, T., Ihara, T., Sasaki, M. et al. Effectiveness of combined anticoagulant therapy for extending portal vein thrombosis in Crohn's disease. Dis Colon Rectum 39, 823–825 (1996). https://doi.org/10.1007/BF02054451
Issue Date:
DOI: https://doi.org/10.1007/BF02054451